Pharmaceutical ETF

Fund Name:
Pharmaceutical ETF
Van Eck
Total Net Assets:
Related Index:
ETF Category: 
Expense Ratio: 
Net Asset Value: 
Recent NAV Premium: 
NAV Symbol: 
Annualized Yield: 
Annualized Yield: 
Stock Weight Amount
Pfizer 5.51% $12,306,924
Astrazeneca Plc 5.41% $12,085,600
Sanofi 5.37% $11,982,781
Novo Nordisk A/S 5.36% $11,968,209
Abbvie 5.17% $11,535,399
List of all 25 stocks held by PPH »
Quotes delayed 20 minutes

Buy (3.09 out of 4)
0th percentile
(ranked lower than approx. 100% of all etfs covered)
Based on data provided by Zacks Investment Research via
ETF Assets
GDX   $16,540,719,950
GDXJ   $6,051,406,259
MOAT   $5,767,278,083
SMH   $5,219,987,196
ANGL   $4,848,974,087
List of all 46 others »
Shares Short 204,002
Chg. from Last Month -1,705,998
Shares Outstanding 3,188,138
% of Shares Short 6.40%
Days to Cover 1.0
Based on third party short interest data.

PPH | Pharmaceutical ETF | ETF Channel |

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.